{"title":"利用人尿源性肾上皮细胞模拟遗传性纤毛病肾病","authors":"E. Molinari, J. Sayer","doi":"10.3233/TRD-190034","DOIUrl":null,"url":null,"abstract":"The extreme heterogeneity of renal ciliopathies warrants the use of personalised, patient-specific disease models. Kidney tubular epithelia are exposed to continuous passage of filtrate and viable renal tubular cells are excreted daily in the urine, representing a non-invasive source of patient primary material. These cells can be isolated, cultured and employed for a range of applications, from disease modelling to ex vivo drug testing.","PeriodicalId":75246,"journal":{"name":"Translational science of rare diseases","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/TRD-190034","citationCount":"4","resultStr":"{\"title\":\"Using human urine-derived renal epithelial cells to model kidney disease in inherited ciliopathies\",\"authors\":\"E. Molinari, J. Sayer\",\"doi\":\"10.3233/TRD-190034\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The extreme heterogeneity of renal ciliopathies warrants the use of personalised, patient-specific disease models. Kidney tubular epithelia are exposed to continuous passage of filtrate and viable renal tubular cells are excreted daily in the urine, representing a non-invasive source of patient primary material. These cells can be isolated, cultured and employed for a range of applications, from disease modelling to ex vivo drug testing.\",\"PeriodicalId\":75246,\"journal\":{\"name\":\"Translational science of rare diseases\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.3233/TRD-190034\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational science of rare diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3233/TRD-190034\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational science of rare diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/TRD-190034","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Using human urine-derived renal epithelial cells to model kidney disease in inherited ciliopathies
The extreme heterogeneity of renal ciliopathies warrants the use of personalised, patient-specific disease models. Kidney tubular epithelia are exposed to continuous passage of filtrate and viable renal tubular cells are excreted daily in the urine, representing a non-invasive source of patient primary material. These cells can be isolated, cultured and employed for a range of applications, from disease modelling to ex vivo drug testing.